Barclays’s BioNTech BNTX Stock Holding History

Barclays’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-22,500	Closed	-$2.05M	–	5274
2025 Q1	$2.05M	Hold	22,500	–	–	﹤0.01%	2608
2024 Q4	$2.56M	Buy	+22,500	New	+$2.57M	﹤0.01%	2701
2024 Q3	–	Sell	-45,000	Closed	-$3.62M	–	5304
2024 Q2	$3.62M	Buy	+45,000	New	+$4.11M	﹤0.01%	1737
2024 Q1	–	Sell	-15,000	Closed	-$1.58M	–	5092
2023 Q4	$1.58M	Buy	+15,000	New	+$1.51M	﹤0.01%	3099
2023 Q2	–	Sell	-15,000	Closed	-$1.87M	–	4582
2023 Q1	$1.87M	Sell	15,000 -38,400	-72%	-$5.27M	﹤0.01%	2244
2022 Q4	$8.02M	Buy	+53,400	New	+$8.22M	﹤0.01%	1324

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Barclays's BNTX Position: Q2 2026 in Review

Barclays increased its BioNTech (BNTX) stake by 21% in Q2 2026, buying an estimated $3.03M and bringing the position to 184,663 shares worth $17.2M. The position accounts for ﹤0.01% of the portfolio, ranked #1213.

Barclays first reported a position in BNTX in Q1 2022 and has held it in 18 quarters since. The position peaked at $26.1M in Q1 2022. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Barclays held 184,663 shares of BioNTech worth $17.2M as of Q2 2026.
Barclays bought 32,190 BioNTech shares in Q2 2026, an estimated $3.03M.
BioNTech made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #1213 holding.
Barclays first reported a position in BioNTech in Q1 2022 and has held it in 18 quarters since.
Barclays's BioNTech position peaked at $26.1M in Q1 2022.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.